Human primary-cell assays
Assays can be performed at scale using blood and tissue from healthy volunteers and patients with defined disease.
Source: LinkedIn company description · Retrieved October 13, 2026
Celentyx is a contract research organisation focused on bespoke drug discovery services in human immunology.
Celentyx is based in Oxford and Birmingham, UK. The scientific team develops and provides assays using human primary cells across all stages of the drug discovery pipeline.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Assays can be performed at scale using blood and tissue from healthy volunteers and patients with defined disease.
Source: LinkedIn company description · Retrieved October 13, 2026
Platforms enable high-resolution human immune-system analysis for target discovery, screening, candidate selection, mechanism-of-action and biomarker studies.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 15, 2026, September 19, 2026 and September 27, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.